INSR and diabetes mellitus: Chronic mTORC1 stimulation with autophagy inhibition in hepatocytes was reported to lead to insulin resistance and type 2 diabetes mellitus (DM) mainly via the inhibition of phosphorylation of insulin receptor substrates [32].